Vigabatrin
- Product NDC
- 59651-366
- 11-digit product format
- 596510366
- Labeler code
- 59651
- Product ID
- 59651-366_7fa314e2-0506-4061-9058-435a3b5df40d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Vigabatrin
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA213899
- Marketing category
- ANDA
- Marketing start
- 2021-09-29
- Substance
- VIGABATRIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Vigabatrin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| VIGABATRIN | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GR120KRT6K |
| Rxcui | 250820 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59651-366-07 | Vigabatrin | 1 in 1 PACKET | POWDER, FOR SOLUTION | 1 | | 5 |
| 59651-366-50 | Vigabatrin | 50 in 1 CARTON | POWDER, FOR SOLUTION | 50 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59651-366 | VIGABATRIN POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED] | 4 | Current NDC, Legacy NDC, 2 package rows | 20240121_c97ce40c-1c5a-479d-9188-5ce03cf7e065.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59651-366-07 | 59651036607 | 1 in 1 PACKET | | | | | | Historical |
| 59651-366-50 | 59651036650 | 50 PACKET in 1 CARTON (59651-366-50) / 1 POWDER, FOR SOLUTION in 1 PACKET (59651-366-07) | 50 packet | 2021-09-29 | 0000-00-00 | No | No | Current |